Literature DB >> 16549260

Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.

S Teerenstra1, R J F Melis, P G M Peer, G F Borm.   

Abstract

BACKGROUND AND OBJECTIVES: When contamination is present, randomization on a patient level leads to dilution of the treatment effect. The usual solution is to randomize on a cluster level, but at the cost of efficiency and more importantly, this may introduce selection bias. Furthermore, it may slow down recruitment in the clusters that are randomized to the "less interesting" treatment. We discuss an alternative randomization procedure to approach these problems.
METHODS: Pseudo cluster randomization is a two-stage randomization procedure that balances between individual randomization and cluster randomization. For common scenarios, the design factors needed to calculate the appropriate sample size are tabulated.
RESULTS: A pseudo cluster randomized design can reduce selection bias and contamination, while maintaining good efficiency and possibly improving enrollment. To make a well-informed choice of randomization procedure, we discuss the advantages of each method and provide a decision flow chart.
CONCLUSION: When contamination is thought to be substantial in an individually randomized setting and a cluster randomized design would suffer from selection bias and/or slow recruitment, pseudo cluster randomization can be considered.

Entities:  

Mesh:

Year:  2006        PMID: 16549260     DOI: 10.1016/j.jclinepi.2005.10.003

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Single versus multicomponent intervention in frail elderly: simplicity or complexity as precondition for success?

Authors:  S Vliek; R J Melis; M Faes; G A Golüke-Willemse; B J de Leest; E Meeuwsen; F H J M van Raak; C J M Schölzel-Dorenbos; M G M Olde Rikkert
Journal:  J Nutr Health Aging       Date:  2008-05       Impact factor: 4.075

Review 2.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

Review 3.  Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization.

Authors:  Brian W Pence; Bradley N Gaynes; Nathan M Thielman; Amy Heine; Michael J Mugavero; Elizabeth L Turner; Evelyn B Quinlivan
Journal:  Am J Epidemiol       Date:  2015-12-01       Impact factor: 4.897

4.  The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.

Authors:  Brian W Pence; Bradley N Gaynes; Julie L Adams; Nathan M Thielman; Amy D Heine; Michael J Mugavero; Teena McGuinness; James L Raper; James H Willig; Kristen G Shirey; Michelle Ogle; Elizabeth L Turner; E Byrd Quinlivan
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

5.  Consensus report of the coalition for clinical research-self-monitoring of blood glucose.

Authors:  David C Klonoff; Richard Bergenstal; Lawrence Blonde; Suzanne Austin Boren; Timothy S Church; Jenifer Gaffaney; Lois Jovanovic; David M Kendall; Craig Kollman; Boris P Kovatchev; Claudia Leippert; David R Owens; William H Polonsky; Gérard Reach; Eric Renard; Michael C Riddell; Richard R Rubin; Oliver Schnell; Linda M Siminiero; Robert A Vigersky; Darrell M Wilson; Alison Okada Wollitzer
Journal:  J Diabetes Sci Technol       Date:  2008-11

6.  The design of the Dutch EASYcare study: a randomised controlled trial on the effectiveness of a problem-based community intervention model for frail elderly people [NCT00105378].

Authors:  René J F Melis; Monique I J van Eijken; George F Borm; Michel Wensing; Eddy Adang; Eloy H van de Lisdonk; Theo van Achterberg; Marcel G M Olde Rikkert
Journal:  BMC Health Serv Res       Date:  2005-10-05       Impact factor: 2.655

7.  Group autonomy enhancing treatment versus cognitive behavioral therapy for anxiety disorders: A cluster-randomized clinical trial.

Authors:  Laura E Kunst; Joyce Maas; Anton J L M van Balkom; Marcel A L M van Assen; Brenda Kouwenhoven; Marrie H J Bekker
Journal:  Depress Anxiety       Date:  2021-12-24       Impact factor: 8.128

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.